טוען...
Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?
The treatment of advanced lung cancer has become increasingly personalized over the past decade as a result of the improved understanding of tumor molecular biology and anti-tumor immunity. An adequate tumor sample is central to targetable mutation analysis, and immunologic profiling. The majority o...
שמור ב:
| הוצא לאור ב: | J Thorac Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330770/ https://ncbi.nlm.nih.gov/pubmed/32642252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-19-4119 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|